Cargando…
Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients?
A perspective from the innovative industry is provided in this article about the long awaited legal proposal for a Clinical Trial Regulation (“Proposal”), adopted in July 2012. With this Proposal, the European Commission reacted to a call by all stakeholders for more harmonization and streamlining o...
Autores principales: | Atzor, Sabine, Gokhale, Surendra, Doherty, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622747/ https://www.ncbi.nlm.nih.gov/pubmed/23585715 http://dx.doi.org/10.1007/s40290-013-0012-8 |
Ejemplares similares
-
Medicines Regulation in Africa: Current State and Opportunities
por: Ndomondo-Sigonda, Margareth, et al.
Publicado: (2017) -
Scale-up of industrial microbial processes
por: Crater, Jason S, et al.
Publicado: (2018) -
EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research
por: Seppala, L. J., et al.
Publicado: (2019) -
Bringing lived experience into research: good practices for public
involvement in research
por: Davis, S Fowler, et al.
Publicado: (2022) -
Financing Drug Innovation in the US: Current Framework and Emerging Challenges
por: Cutler, David, et al.
Publicado: (2020)